Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS) Stock
—
Valuation
Financials & Margins
Latest News
Valuation & Return Ratios
Ownership
About Tonghua Dongbao Pharmaceutical Co., Ltd.
—
Tonghua Dongbao Pharmaceutical Co., Ltd. is led by CEO Jiahong Li, employs 3,354 people, headquartered in Tonghua, CN, publicly traded since 1994.
Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS) stock trades at $7.62 with a market capitalization of $15.32B. The stock is valued at a price-to-earnings (P/E) ratio of 11.85, price-to-book of 2.09, price-to-sales of 4.94. Over the past 52 weeks the stock has ranged between $7.16 and $10.67, and currently trades 28.6% below its 52-week high. It pays a dividend yielding 3.87%.
On profitability, Tonghua Dongbao Pharmaceutical Co., Ltd. generates a return on equity (ROE) of 19.47%, above the typical market range of roughly 12-15%, an operating margin of 19.76%, a net profit margin of 41.88%.
The balance sheet shows a debt-to-equity ratio of 0.10 (debt below half of shareholders' equity), a current ratio of 3.63.
600867.SS has an average daily trading volume of 31,158,401 shares, a beta of 0.14 (historically less volatile than the overall market), 1.96B shares outstanding.
Official website: thdb.com
Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS) — frequently asked questions
What is Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS) stock price today?
Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS) is currently trading at $7.62, down 1.42% today.
What is 600867.SS P/E ratio?
Tonghua Dongbao Pharmaceutical Co., Ltd.'s P/E ratio is 11.85. This is below the typical market average of roughly 18-22x. A low P/E can reflect a lower valuation, slower expected growth, or both.
What is 600867.SS return on equity (ROE)?
Tonghua Dongbao Pharmaceutical Co., Ltd.'s return on equity (ROE) is 19.47%. ROE measures net income relative to shareholders' equity. This is above the typical market range of roughly 12-15%.
What is Tonghua Dongbao Pharmaceutical Co., Ltd.'s market cap?
Tonghua Dongbao Pharmaceutical Co., Ltd. has a market capitalization of $15.32B.
Does 600867.SS pay a dividend?
Yes. Tonghua Dongbao Pharmaceutical Co., Ltd. currently yields 3.87%. Yield moves with the share price, so it changes daily even when the payment does not.
How much debt does 600867.SS carry?
Tonghua Dongbao Pharmaceutical Co., Ltd. has a debt-to-equity ratio of 0.10. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is 600867.SS's profit margin?
Tonghua Dongbao Pharmaceutical Co., Ltd. reports a net profit margin of 41.88% — the share of revenue left after every cost, including tax and interest.
What sector is 600867.SS in?
Tonghua Dongbao Pharmaceutical Co., Ltd. is classified under —, in the — industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is 600867.SS listed on?
Tonghua Dongbao Pharmaceutical Co., Ltd. trades on SHH under the ticker 600867.SS.
What is 600867.SS's 52-week range?
Over the last year Tonghua Dongbao Pharmaceutical Co., Ltd. has traded between $7.16 and $10.67.
Related — Stocks
Popular Stocks
Screens 600867.SS currently matches
On the figures above, Tonghua Dongbao Pharmaceutical Co., Ltd. passes the filters for 22 of our ready-made screens, among them Low PE Stocks, Cheap Stocks To Buy Now, Undervalued Large Cap Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.